April 21, 2011 /
With no competition, shall there be higher prices?
April 21, 2011
(Source: Datamonitor)
Acorda Therapeutics, Inc., a biotechnology company, has announced that the US Patent and Trademark Office has allowed US patent application entitled Sustained Release Aminopyridine Composition.
April 21, 2011
(Source: Datamonitor)
Acorda Therapeutics, Inc., a biotechnology company, has announced that the US Patent and Trademark Office has allowed US patent application entitled Sustained Release Aminopyridine Composition.
The claims of the patent application relate to methods to improve walking in patients with multiple sclerosis (MS) by administering 10 mg of sustained release 4-aminopyridine (dalfampridine) twice daily. The patent that issues from this application, which will be eligible for listing in the FDA Orange Book, is set to expire in early February 2026, based on the USPTO’s calculated patent term adjustment of 413 days, which the Company is currently evaluating.
AMPYRA (dalfampridine) Extended Release Tablets, 10 mg is marketed in the US by Acorda Therapeutics, Inc. It is approved in the Unites States as a treatment to improve walking in people with MS. This was demonstrated by an increase in walking speed.
A service of YellowBrix, Inc
****************************************************************
Remain CURRENT with Multiple Sclerosis information
when registered at the MS Views and News website
.
***************************************************************************************
.
“Providing You with ‘MS Views and News’, is what we do“
***************************************************************************************
.
Disclaimer: ‘MS Views and News’ (MSVN), does not endorse any products or services found on this blog. It is up to you to seek advice from your healthcare provider. The intent of this blog is to provide information on various medical conditions, medications, treatments, and procedures for your personal knowledge and to keep you informed of current health-related issues. It is not intended to be complete or exhaustive, nor is it a substitute for the advice of your physician. Should you or your family members have any specific medical problem, seek medical care promptly.
.
****************************************************************
Visit our MS Learning Channel on YouTube: http://www.youtube.com/msviewsandnews
Stay informed with MS news and information - Sign-up here
For MS patients, caregivers or clinicians, Care to chat about MS? Join Our online COMMUNITY CHAT
